Associate Professor of Medicine / Leader, Lymphoma Program
Hematology
Dr. Timothy S. Fenske, MD
|
|
Give Review
Dr. Timothy S. Fenske practices Hematology. He went to medical school at University of Wisconsin School of Medicine and Public Health. He received 2 awards: "Murphy Award for Clinical Excellence" and "CMS Meaningful Use Stage 1 Certification". Timothy Fenske is a published doctor and has 36 publications published. The lastest was: 'Alteration of the CD34+ Tf-1 beta cell line profile in response to long-term exposure to IL-15.' Timothy Fenske is registered with Medicare and accepts Medicare payments.
Publications
- Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin Lymphoma.
- Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?
- A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin Lymphoma.
- Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor Cells (HPC) in AL amyloidosis.
- Impact of induction regimen and stem cell transplantation on outcomes in double-hit Lymphoma: a multicenter retrospective analysis.
- Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transpla...
- Limited utility of routine surveillance imaging for classical hodgkin Lymphoma patients in first complete remission.
- Outcomes of hematopoietic cell transplantation for diffuse large B cell Lymphoma transformed from follicular Lymphoma.
- Rituximab is associated with improved survival in Burkitt Lymphoma: a retrospective analysis from two US academic medical centers.
- Allogeneic hematopoietic cell transplantation for diffuse large B cell Lymphoma: who, when and how?
- Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation...
- Autologous haematopoietic cell transplantation for non-Hodgkin Lymphoma with secondary CNS involvement.
- Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma.
- Divergent Effects of Novel Immunomodulatory Agents and Cyclophosphamide on the Risk of EnGraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation...
- Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 ToSitumomab/BEAM With Autologous Hematopoietic...
- Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III ...
- Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell Lymphoma: a cohort analysis from the center for international blood and marrow ...
- Autologous and allogeneic transplantation for burkitt Lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transpl...
- Follicular Lymphoma: prognostic factors, conventional therapies, and hematopoietic cell transplantation.
- A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin Lymphoma.
- Central Nervous system Hodgkin lymphoma: case report and review of the literature.
- CD23 expression in follicular Lymphoma: clinicopathologic correlations.
- Successful management of pregnancy occurring in a patient with chronic myeloid Leukemia on dasatinib.
- Follicular Lymphoma transformation to dual translocated Burkitt-like Lymphoma: improved disease control associated with radiation therapy.
- Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell Lymphoma.
- Treatment of diffuse large B-cell Lymphoma of the liver with yttrium-90 microsphere embolization.
- Does autologous transplantation directly increase the risk of secondary Leukemia in lymphoma patients?
- Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
- Identification of candidate alkylator-induced Cancer susceptibility genes by whole genome scanning in mice.
- Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mant...
- Dominant negative effects of the AML1/ETO fusion oncoprotein.
- Stem Cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice.
- Alteration of the CD34+ Tf-1 beta Cell line profile in response to long-term exposure to IL-15.
- Two novel HLA-DQB1*06 alleles reveal additional heterogeneity of HLA-DQw1.
- Characterization of a novel DQB1 allele associated with HLA-DQw3: implications for oligotyping.
Schools
University Of Wisconsin Medical School
University Of Wi Hospital and Cli
Washington UB JhSlch Conc
Procedures Preformed
- Bone Marrow Transplant
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- View All
Conditions Treated
- Acute Leukemia
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Murphy Award for Clinical Excellence
- CMS Meaningful Use Stage 1 Certification
Education
-
Washington University -
University of Wisconsin -
University of Wisconsin School of Medicine and Public Health
Hospital
-
Froedtert Memorial Lutheran Hospital
Drug Facts
| NPI NUMBER | 1104877935 | |
| NPPES Provider LastName | FENSKE | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 532263522 | |
| NPPES Provider State | WI | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 335.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 5.07 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104877935 |
| Last Name Of The Provider | FENSKE |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
Rebecca R. Rusch, APNP |
|
Dr. Christopher Chitambar, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Leena Maramattom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carlos E. Arce-Lara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prabhas Mittal, MD |
|
|
Dr. Joshua Field, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Joan C. Gill, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Robert B. Hall, MD |
|
|
Dr. Michael W. Schuetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parameswaran N. Hari, MD |
|
Dr. J Frank Wilson, MD |
|
Amy R. Newman, APNP |